RIN Institute Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for RIN Institute Inc..The latest application filed is for "antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and cancer drug including same".

Company Profile

6.8.5

RIN Institute Inc. - Chuo-ku N/A JP
RIN INSTITUTE INC. - Tokyo JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and cancer drug including same Grant 11,377,504 - Matsumura , et al. July 5, 2	2022-07-05
Plasmin-cleavable anti-insoluble fibrin antibody-drug conjugate Grant 11,311,626 - Matsumura , et al. April 26, 2	2022-04-26
Antibody binding to TMEM132A, anticancer agent, and cancer test method Grant 11,192,956 - Matsumura , et al. December 7, 2	2021-12-07
Antibody Beneficial For Treatment Of Solid Tumors, Antibody-drug Conjugate, And Cancer Drug Including Same App 20210221911 - MATSUMURA; Yasuhiro ; et al.	2021-07-22
Plasmin-cleavable Anti-insoluble Fibrin Antibody-drug Conjugate App 20200147231A1 -	2020-05-14
Cancer-Cell-Specific Antibody, Anticancer Drug, and Cancer Testing Method App 20200078458 - Matsumura; Yasuhiro ; et al.	2020-03-12
Cancer-cell-specific anti-transmembrane protein 180 antibody, anticancer drug, and cancer testing method Grant 10,471,146 - Matsumura , et al. Nov	2019-11-12
Antibody Binding To Tmem132a, Anticancer Agent, And Cancer Test Method App 20190225704 - MATSUMURA; Yasuhiro ; et al.	2019-07-25
Anti-tmem-180 Antibody, Anticancer Drug And Cancer Testing Method App 20190060480 - MATSUMURA; Yasuhiro ; et al.	2019-02-28
Cancer-Cell-Specific Antibody, Anticancer Drug, and Cancer Testing Method App 20170260284 - Matsumura; Yasuhiro ; et al.	2017-09-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.